104 related articles for article (PubMed ID: 9369408)
21. Ifosfamide in the treatment of head and neck cancer.
Airoldi M; Cortesina G; Giordano C; Pedani F; Bumma C
Oncology; 2003; 65 Suppl 2():37-43. PubMed ID: 14586145
[TBL] [Abstract][Full Text] [Related]
22. Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.
Peng PJ; Ou XQ; Chen ZB; Liao H; Peng YL; Wang SY; Zhang HY; Lin Z
Cancer Chemother Pharmacol; 2013 Aug; 72(2):323-8. PubMed ID: 23728706
[TBL] [Abstract][Full Text] [Related]
23. The standard to come: systemic therapies for systemic disease.
Vokes EE; Liebowitz D
Cancer J Sci Am; 1995; 1(3):184-6. PubMed ID: 9166473
[No Abstract] [Full Text] [Related]
24. [Chemotherapy of metastatic nasopharyngeal cancer].
Bodemann HH
Strahlentherapie Sonderb; 1984; 78():174-9. PubMed ID: 6729903
[No Abstract] [Full Text] [Related]
25. Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma.
Hsieh CH; Hsu CL; Wang CH; Liaw CC; Chen JS; Chang HK; Yang TS; Chang JW; Lin YC; Liau CT; Tsang NM; Chang JT; Ng SH; Wang HM
Biomed J; 2013; 36(5):229-36. PubMed ID: 24225189
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant chemotherapy for advanced nasopharyngeal carcinoma.
Dimery IW; Legha SS; Peters LJ; Goepfert H; Oswald MJ
Cancer; 1987 Sep; 60(5):943-9. PubMed ID: 3607731
[TBL] [Abstract][Full Text] [Related]
27. Induction chemotherapy followed by alternating chemo-radiotherapy in stage IV undifferentiated nasopharyngeal carcinoma.
Benasso M; Sanguineti G; D'Amico M; Corvò R; Ricci I; Numico G; Guarneri D; Vitale V; Pallestrini E; Santelli A; Rosso R
Br J Cancer; 2000 Dec; 83(11):1437-42. PubMed ID: 11076650
[TBL] [Abstract][Full Text] [Related]
28. Etoposide (VP-16), ifosfamide/mesna, and cisplatin chemotherapy for advanced and recurrent carcinoma of the cervix.
Kredentser DC
Gynecol Oncol; 1991 Nov; 43(2):145-8. PubMed ID: 1743556
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of tumoral and lymph node response to neoadjuvant chemotherapy in undifferentiated nasopharyngeal carcinoma].
Frikha M; Bouaziz M; Daoud J; Ghorbel A; Elloumi M; Boudaya M; Jlidi R; Souissi T; Kechaou MS; Drira MM
Bull Cancer; 1997 Mar; 84(3):273-6. PubMed ID: 9207873
[TBL] [Abstract][Full Text] [Related]
30. [Preliminary results of ifosfamide and doxorubicin regimen in treatment of patients with recurrent and metastatic nasopharyngeal carcinoma].
Huang HQ; Zhou ZM; Li YH; Jiang WQ; He YJ; Teng XY; Guan ZZ
Ai Zheng; 2002 Apr; 21(4):409-11. PubMed ID: 12452022
[TBL] [Abstract][Full Text] [Related]
31. Experience with bleomycin, ifosfamide, and cisplatin in primary and recurrent cervical cancer.
Buxton EJ
Semin Oncol; 1992 Apr; 19(2 Suppl 5):9-17; discussion 17-8. PubMed ID: 1384148
[TBL] [Abstract][Full Text] [Related]
32. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival.
;
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):463-9. PubMed ID: 8655368
[TBL] [Abstract][Full Text] [Related]
33. Alternating chemo-radiotherapy with cisplatin and 5-fluorouracil plus bleomycin by continuous infusion for locally advanced undifferentiated carcinoma nasopharyngeal type.
Azli N; Armand JP; Rahal M; Wibault P; Boussen H; Eschwege F; Schwaab G; Gasmi J; Bachouchi M; Cvitkovic E
Eur J Cancer; 1992; 28A(11):1792-7. PubMed ID: 1382499
[TBL] [Abstract][Full Text] [Related]
34. Combination of docetaxel, ifosfamide and cisplatin (DIP) as a potential salvage chemotherapy for metastatic urothelial carcinoma.
Kakutani S; Fukuhara H; Taguchi S; Nagata M; Niimi A; Hattori M; Miyazaki H; Fujimura T; Nakagawa T; Kume H; Igawa Y; Homma Y
Jpn J Clin Oncol; 2015 Mar; 45(3):281-5. PubMed ID: 25425701
[TBL] [Abstract][Full Text] [Related]
35. Influence of immediate post-therapy bone scintigraphy in the assessment of response to therapy in a case of nasopharyngeal carcinoma.
Kostakoglu L; Ozyar E; Uysal U; Elahi N; Uzal D; Kars A; Atahan L; Bekdik CF
Radiat Med; 1996; 14(5):279-81. PubMed ID: 8988509
[TBL] [Abstract][Full Text] [Related]
36. Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases.
Gebbia V; Zerillo G; Restivo G; Speciale R; Cupido G; Lo Bue P; Ingria F; Gallina S; Spatafora G; Testa A
Br J Cancer; 1993 Jul; 68(1):191-4. PubMed ID: 7686391
[TBL] [Abstract][Full Text] [Related]
37. Salvage chemotherapy with a combination of paclitaxel, ifosfamide, and cisplatin for the patients with recurrent carcinoma of the uterine cervix.
Choi CH; Kim TJ; Lee SJ; Lee JW; Kim BG; Lee JH; Bae DS
Int J Gynecol Cancer; 2006; 16(3):1157-64. PubMed ID: 16803500
[TBL] [Abstract][Full Text] [Related]
38. Induction chemotherapy followed by alternating chemo-radiotherapy in non-endemic undifferentiated carcinoma of the nasopharynx: optimal compliance and promising 4-year results.
Ponzanelli A; Vigo V; Marcenaro M; Bacigalupo A; Gatteschi B; Ravetti JL; Corvò R; Benasso M
Oral Oncol; 2008 Aug; 44(8):767-74. PubMed ID: 18061519
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
40. Central pontine myelinolysis: report of two occurrences after cisplatin-containing chemotherapy for nasopharyngeal carcinoma.
Yau TK; Yiu HY; Lee WM
Clin Oncol (R Coll Radiol); 1993; 5(6):395-6. PubMed ID: 8305365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
